Sivan Bercovici

Company: Karius

Job title: Chief Technology Officer

Seminars:

Liquid Biopsy for Pathogens: Diagnosing Infections in Cancer Patients and an Emerging Biomarker Frontier 2:45 pm

Infections play a critical role in cancer patients’ course of disease and outcome, with approximately 50% of deaths in cancer patients thought to be linked to infections as a primary or associated cause of death Microbial cell-free DNA (mcfDNA) offers a liquid biopsy solution for infectious disease diagnostics with established value for immunocompromised patients As…Read more

day: Day Two